COMMITTEE ON ENERGY AND COMMERCE (House)
Bills and resolutions
Investigations and studies: expenses (see H. Res. 354), H397 [7FE]
Explanations
Interception of cellular telecommunications, E3315 [29OC]
Hearings
Agency for Health Care Policy and Research: (testimony), D876 [20JY]
AIDS research opportunities: (testimony), D142 [24FE]
Amtrak appropriations (H.R. 4250): (testimony), D129 [20FE]
Anti-Car Theft Act and related legislation (H.R. 4542, 4220, 4228, 4230): (testimony), D1093 [10SE]
Anticompetitive petroleum pricing practices by refiners (H.R. 2966): (testimony), D709 [11JN]
Audio Home Recording Act (H.R. 4567): (testimony), D371 [31MR]
Auto industry: (testimony), D484 [30AP]
Bell Operating Companies restrictions: (testimony), D631 [27MY]
Billing practices of EPA superfund contractor, CH2M Hill, Inc.: (testimony), D303 [19MR]
Clean Air Act implementation: (testimony), D88 [7FE]
Clinical laboratory improvements implementation and problems plaguing the medicaid program: (testimony), D470 [29AP]
Consumer Product Safety Commission funding and Toy Injury Reduction Act (H.R. 3809): (testimony), D160 [26FE]
Contaminated Federal facilities scheduled for closure: (testimony), D442 [9AP]
Control of greenhouse emissions: (testimony), D303 [19MR]
Dept. of Energy appropriations: (testimony), D150 [25FE]
Domestic and international climate change policy: (testimony), D201 [3MR]
Elwha River Ecosystem and Fisheries Restoration Act (H.R. 4844): (testimony), D872 [9JY]
EPA contract management: (testimony), D865 [8JY]
EPA groundwater policies: (testimony), D129 [20FE]
EPA's criminal enforcement program: (testimony), D1094 [10SE]
EPA's mismanagement of Computer Sciences Corp. contracts: (testimony), D211 [4MR]
FDA approval of medical devices: (testimony), D661 [3JN]
FDA drug approval process: (testimony), D84 [6FE]
FDA issuing of regulations: (testimony), D383 [1AP]
Federal Railroad Administration and OSHA responsibility for railroad safety: (testimony), D1005 [5AU]
Federal research contracts and grants: (testimony), D38 [29JA]
Fertility Clinic Success Rate and Certification Act (H.R. 3940): (testimony), D173 [27FE]
Foreign military assistance to Israel: (testimony), D952 [29JY]
Fraud and abuse in medicaid system: (testimony), D813 [29JN]
Government Securities Reform Act (H.R. 3927): (testimony), D118 [19FE]
Granting additional market exclusivity to the drug ANSAID: (testimony), D129 [20FE]
Health care and insurance costs: (testimony), D74 [5FE]
Hospital industry's financial practices and viability: (testimony), D292 [18MR]
Hours of Service Act: (testimony), D698 [10JN]
Impact of State and Federal natural gas rules: (testimony), D865 [8JY]
Insurance company insolvencies: (testimony), D442 [9AP], D1083 [9SE]
Insurance rating companies, D38 [29JA]
Investment Advisors Act reform: (testimony), D673 [4JN], D698 [10JN]
Labeling and marking of tropical wood and wood products (H.R. 2854): (testimony), D560 [13MY]
Lead poisoning impact on low-income and minority communities: (testimony), D150 [25FE]
Long-term care insurance: (testimony), D607 [20MY], D912 [23JY]
Mammography services: (testimony), D680 [5JN]
Medicaid managed care and providers that serve the poor: (testimony), D1025 [7AU]
Medical device manufacturing regulations: (testimony), D336 [25MR]
National Waste Reduction, Recycling, and Management Act (H.R. 3865): (testimony), D241 [10MR]
Native Hawaiian Health Care Improvement Act (H.R. 5346): (testimony), D876 [20JY]
Prescription drugs (H.R. 2890, 3405, and 5614: (testimony), D972 [31JY]
Private health insurance administrative costs: (testimony), D129 [20FE]
Radon Awareness and Disclosure Act (H.R. 3258): (testimony), D661 [3JN]
Rail labor disputes: (testimony), D784 [24JN]
Regulations on pregnancy options counseling: (testimony), D361 [30MR]
Renewable Energy and Efficiency Technology Competitiveness Act: (testimony), D38 [29JA]
Rural Rental Housing Program investor problems: (testimony), D560 [13MY]
Small market health insurance reform: (testimony), D572 [14MY]
Solid Waste Disposal Act authorization (H.R. 3865): (testimony), D273 [16MR]
State medicaid programs: (testimony), D348 [26MR]
Telecommuting Act (H.R. 5082): (testimony), D952 [29JY]
Telephone Network Reliability Improvement Act: (testimony), D413 [7AP], D560 [13MY]
Telephone toll fraud: (testimony), D709 [11JN]
Textile fraud impact on interstate and foreign commerce: (testimony), D528 [7MY]
Trade Enhancement Act: (testimony), D222 [5MR], D336 [25MR], D426 [8AP]
User fees for prescription drugs: (testimony), D1037 [10AU]
Women's sports and gender equity: (testimony), D442 [9AP]
Yew tree lands management: (testimony), D781 [24JN]
Letters
Consumer Protection Telemarketing Act, H9694 [29SE]
U.S. participation in U.N. Conference on Environment and Development: Representative Dingell, H1307 [17MR]
Verification of weights relative to intermodal transportation, H11276 [4OC]
Lists
Staff that worked on the Comprehensive National Energy Policy Act, H11432 [5OC]
Meetings
Amtrak Capital Acquisition and Technology Development Act (H.R. 4250), D222 [5MR]
Authorizing appropriations for the Solid Waste Disposal Act (H.R. 3865), D336 [25MR]
Breast Cancer Prevention and Safety Act, D1113 [15SE]
Cable Television Consumer Protection and Competition Act, D372 [31MR], D383 [1AP], D426 [8AP]
CERCLA amendments relative to Federal identification of real property free of hazardous substances (H.R. 4016), D560 [13MY]
Certification of embryo laboratories (H.R. 3940), D348 [26MR]
Consumer Product Safety Act appropriations (H.R. 4706), D394 [2AP]
Consumer protection and competition in cable television (H.R. 4850), D731 [16JN]
Copyright treatment of digital audio recording (H.R. 4567), D551 [12MY]
Dept. of Veterans Affairs drug price limits (H.R. 2890), D1113 [15SE]
DES education and research amendments (H.R. 4178), D912 [23JY]
Extend Consumer Products Safety Act authorization appropriations (H.R. 4706), D740 [17JN]
Extension of a certain health maintenance organization waiver (H.R. 4252), D1113 [15SE]
Federal Program Improvement Act amendment (H.R. 3837), D912 [23JY]
Financial Fraud Detection and Disclosure Act (H.R. 4313), D872 [9JY]
Government Securities Reform Act (H.R. 3047, 3927), D529 [7MY]
Health care assistance (H.R. 3591, 5346, and 5673), D963 [30JY]
Indian health program appropriations (H.R. 3724), D348 [26MR]
Investment Advisory Regulatory Enhancement and Disclosure Act, D963 [30JY]
Lead Exposure Reduction Act (H.R. 3554), D394 [2AP]
Mammography Quality Standards Act (H.R. 5938), D1123 [16SE]
National Waste Reduction, Recycling, and Management Act (H.R. 3865), D824 [30JN], D836 [1JY]
Petroleum Marketing Competition Enhancement Act (H.R. 2966), D1050 [11AU]
Petroleum Marketing Practices Act amendments (H.R. 5000), D484 [30AP]
Prescription Drug User Fee Act, D1113 [15SE]
Radon Awareness and Disclosure Act (H.R. 3258), D1050 [11AU], D1134 [17SE]
Reauthorizing research programs on Alzheimer's disease (H.R. 3082), D348 [26MR]
Relation of trade agreements to health, safety, labor, and environmental laws of the U.S. (H. Con. Res. 246), D551 [12MY]
Settlement of railroad labor-management disputes (H.J. Res. 515), D797 [25JN]
Solid Waste Disposal Act authorization (H.R. 3865), D326 [24MR], D349 [26MR]
Study of insurance industry (H.R 4731), D951 [29JY]
Remarks in House
District of Columbia: role of the Pennsylvania Avenue Development Corp., E1846 [16JN]
Ecology and environment: environmental racism allegations, E439 [26FE]
EPA: treatment of contractors, E1782 [11JN]
Meetings: during sessions, H1585 [20MR], H2046 [31MR], H4698 [16JN], H4761 [17JN], H5100 [24JN], H7972 [11AU]
Staff: tribute, H3812 [27MY]
Reports filed
Activities for the 102d Congress, 1st Session (H. Rept. 102-455), H1290 [16MR]
Agency for Health Care Policy and Research Reauthorization (H.R. 5673) (H. Rept. 102-892), H8964 [22SE]
Auto Theft Prevention (H.R. 4542) (H. Rept. 102-851), H8964 [22SE]
Block Grants To Enhance Services for Mental Health and Substance Abuse Programs (H.R. 3698) (H. Rept. 102-464), H1690 [24MR]
Conference Report on Cable Television Consumer Protection Act (S. 12) (H. Rept. 102-862), H8357 [14SE]
Consumer Products Safety Act Appropriations (H.R. 4706) (H. Rept. 102-649), H5978 [2JY]
Consumer Protection and Competition in Cable Television (H.R. 4850) (H. Rept. 102-628), H5541 [29JN]
Diethylstilbestrol Research Program (H.R. 4178) (H. Rept. 102-817), H7883 [10AU]
Extension of a Certain Medicaid Health Maintenance Organization Waiver (H.R. 4252) (H. Rept. 102-887), H8964 [22SE]
FDA Enforcement Authority (H.R. 3642) (H. Rept. 102-1030), H11626 [5OC]
Fraud Detection and Disclosure Obligations on Auditors of Public Companies (H.R. 4313) (H. Rept. 102-890), H8964 [22SE]
Identification of Real Property Where No Hazardous Substance Was Stored Relative to the Termination of Certain Activities (H.R. 4016) (H. Rept. 102-814), H7724 [6AU]
Improve Medicare Administration and Reform Customs Overtime Pay Practices (H.R. 3837) (H. Rept. 102-486), H7255 [3AU]
Improved Accuracy of Products and Services for Radon Testing (H.R. 3258) (H. Rept. 102-923), H9641 [28SE]
Indian Health Program Appropriations (H.R. 3724) (H. Rept. 102-643), H6860 [28JY]
Interstate Telephone Pay-Per-Call Technology Regulation (H.R. 3490) (H. Rept. 102-430), H327 [5FE]
Legal Liability Protections for Health Care Professionals (H.R. 3591) (H. Rept. 102-823), H8357 [14SE]
Limits on Prices of Drugs Procured by the Dept. of Veterans Affairs (H.R. 289) (H. Rept. 102-384), H8964 [22SE]
Medicare Amendments (H.R. 5748) (H. Rept. 102-1046), H12602 [8OC]
Mining Leases of Certain Lands for Oil and Gas Purposes (H.R. 3168) (H. Rept. 102-610), H6626 [24JY]
National Railroad Passenger Corp. Appropriations (H.R. 4250) (H. Rept. 102-513), H3017 [6MY]
Native Hawaiian Health Care (H.R. 5346) (H. Rept. 102-846), H8144 [12AU]
Permission for National Securities Exchanges To Affect Certain Transactions for Which Members Exercise Investment Discretion (H.R. 3047) (H. Rept. 102-858), H8303 [10SE]
Petroleum Marketing Practices Act Amendments (H.R. 5000) (H. Rept. 102-1029), H11626 [5OC]
Pregnancy Success Rates of Assisted Reproductive Technology Programs and Certification of Embryo Laboratories (H.R. 4773) (H. Rept. 102-624), H5541 [29JN]
Prescription Drug Application, Establishment and Product Fees Authorization (H.R. 5952) (H. Rept. 102-895), H8964 [22SE]
Provision for Improved Energy Efficiency (H.R. 776) (H. Rept. 102-474), H2019 [30MR]
Reauthorizing Research Programs on Alzheimer's Disease (H.R. 3082) (H. Rept. 102-623), H5541 [29JN]
Reduction of Levels of Lead in Environment (H.R. 5730) (H. Rept. 102-852), H8218 [9SE]
Regulation of Mammography Services and Radiological Equipment (H.R. 5938) (H. Rept. 102-889), H8964 [22SE]
Relation of Trade Agreements to Health, Safety, Labor, and Environmental Laws of the U.S. (H. Con. Res. 246) (H. Rept. 102-635), H5622 [30JN]
Royalty Payment System and Serial Copy Management System for Digital Audio Recording (H.R. 4567) (H. Rept. 102-780), H7384 [4AU]
Rulemaking Authority Relative To Government Securities Under Federal Laws (H.R. 3927) (H. Rept. 102-722), H6626 [24JY]
Solid Waste Disposal Act Appropriations (H.R. 3865) (H. Rept. 102-839), H8021 [11AU]
Strengthening of the FTC To Protect Consumers From Fraud and Abuse in Sales Made Over the Telephone (H.R. 3203) (H. Rept. 102-688), H6448 [22JY]
Study of Insurance Industry (H.R. 4731) (H. Rept. 102-666), H7883 [10AU]
Supervision of Investment Advisers (H.R. 5726) (H. Rept. 102-883), H8964 [22SE]
Waiver of Medicaid Requirements for Certain Health Maintenance Organizations (H.R. 4572) (H. Rept. 102-494), H2668 [9AP]
Statements
Lead Poisoning: Marjorie Moore, E439 [26FE]